The Substance Abuse and Mental Health Services Administration (SAMHSA) has published new guidance for the care and treatment of substance use disorders during the COVID-19 outbreak. Of note, the guidance includes specific exemptions relating to the provision of methadone and buprenorphine to treat opioid use disorder and addresses other factors that should be considered when providing treatment for alcohol or benzodiazepine withdrawal.
Read the full article: Exemptions and Considerations for the Treatment of Opioid Use Disorder during the COVID-19 Emergency //
Source: https://www.mwe.com/insights/exemptions-and-considerations-for-the-treatment-of-opioid-use-disorder-during-the-covid-19-emergency